Washington, DC, United States
Washington, DC, United States

Time filter

Source Type

Erickson B.,Biotechnology Industry Organization BIO | Singh R.,Biotechnology Industry Organization BIO | Winters P.,Biotechnology Industry Organization BIO
Science | Year: 2011

In our view, synthetic biology is an extension of the continuum of genetic science that has been used safely for more than 40 years by the biotechnology industry in the development of commercial products. Examples of synthetic biology use by biotechnology companies illustrate the potential to substantially reduce research and development time and to increase speed to market. Improvements in the speed and cost of DNA synthesis are enabling scientists to designmodified bacterial chromosomes that can be used in the production of renewable chemicals, biofuels, bioproducts, renewable specialty chemicals, pharmaceutical intermediates, fine chemicals, food ingredients, and health care products. Regulatory options should support innovation and commercial development of new products while protecting the public from potential harms.


Greenwood J.C.,Biotechnology Industry Organization BIO
European Biotechnology Science and Industry News | Year: 2011

Until a decade ago, the United States was the undisputed leader in bioscience industry development. Global competition within the industry has dramatically increased - fueled in large part by low-cost labor, the speed of information dissemination, and available risk capital, in the United States, local and national government leaders continue to understand this new dynamic of increased competition for developing the biosciences and are actively working to expand and promote industry growth.


PubMed | Biotechnology Industry Organization BIO
Type: Journal Article | Journal: Science (New York, N.Y.) | Year: 2011

In our view, synthetic biology is an extension of the continuum of genetic science that has been used safely for more than 40 years by the biotechnology industry in the development of commercial products. Examples of synthetic biology use by biotechnology companies illustrate the potential to substantially reduce research and development time and to increase speed to market. Improvements in the speed and cost of DNA synthesis are enabling scientists to design modified bacterial chromosomes that can be used in the production of renewable chemicals, biofuels, bioproducts, renewable specialty chemicals, pharmaceutical intermediates, fine chemicals, food ingredients, and health care products. Regulatory options should support innovation and commercial development of new products while protecting the public from potential harms.


PubMed | Biotechnology Industry Organization BIO
Type: Journal Article | Journal: Biotechnology journal | Year: 2012

From biomass to renewable chemicals: while industrial biotechnology offers a clear value proposition, a number of hurdles need to be addressed to fully realize the commercial potential of bio-based products and chemicals over the coming decade. A review of an early roadmap for biological production of chemicals from renewable sugars reveals a focus on those that would provide co-products for integrated biorefineries producing biofuels and bioenergy. A growing number of companies are now focusing on specialty chemicals as an entry point to build the bio-based economy.

Loading Biotechnology Industry Organization BIO collaborators
Loading Biotechnology Industry Organization BIO collaborators